Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) was $0.27 for the day, up 7.28% from the previous closing price of $0.25. In other words, the price has increased by $7.28 from its previous closing price. On the day, 0.51 million shares were traded. CDIO stock price reached its highest trading level at $0.2695 during the session, while it also had its lowest trading level at $0.24.
Ratios:
Our analysis of CDIO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.51 and its Current Ratio is at 8.51. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.13.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 06 ’24 when Philibert Robert bought 34,075 shares for $0.29 per share. The transaction valued at 9,763 led to the insider holds 1,683,867 shares of the business.
Dogan Meeshanthini bought 68,965 shares of CDIO for $20,000 on Sep 06 ’24. The Chief Technology Officer now owns 197,310 shares after completing the transaction at $0.29 per share. On Sep 06 ’24, another insider, Dogan Meeshanthini, who serves as the Chief Executive Officer of the company, bought 68,965 shares for $0.29 each. As a result, the insider paid 20,000 and bolstered with 1,683,867 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDIO now has a Market Capitalization of 10732723 and an Enterprise Value of 5909866. For the stock, the TTM Price-to-Sale (P/S) ratio is 287.77 while its Price-to-Book (P/B) ratio in mrq is 2.18. Its current Enterprise Value per Revenue stands at 151.001 whereas that against EBITDA is -0.719.
Stock Price History:
The Beta on a monthly basis for CDIO is 4.52, which has changed by -0.88274336 over the last 52 weeks, in comparison to a change of 0.31181884 over the same period for the S&P500. Over the past 52 weeks, CDIO has reached a high of $3.56, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is 2.29%, while the 200-Day Moving Average is calculated to be -61.55%.
Shares Statistics:
CDIO traded an average of 2.80M shares per day over the past three months and 1827620 shares per day over the past ten days. A total of 25.91M shares are outstanding, with a floating share count of 21.97M. Insiders hold about 15.19% of the company’s shares, while institutions hold 6.42% stake in the company. Shares short for CDIO as of 1730332800 were 1680217 with a Short Ratio of 0.60, compared to 1727654400 on 2795979. Therefore, it implies a Short% of Shares Outstanding of 1680217 and a Short% of Float of 5.52.
Earnings Estimates
The market rating of Cardio Diagnostics Holdings Inc (CDIO) is currently shaped by the ongoing analysis conducted by 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.36 and -$0.36 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.25, with 1.0 analysts recommending between -$0.25 and -$0.25.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $25k to a low estimate of $25k. As of the current estimate, Cardio Diagnostics Holdings Inc’s year-ago sales were $5.31kFor the next quarter, 1 analysts are estimating revenue of $50k. There is a high estimate of $50k for the next quarter, whereas the lowest estimate is $50k.
A total of 1 analysts have provided revenue estimates for CDIO’s current fiscal year. The highest revenue estimate was $59k, while the lowest revenue estimate was $59k, resulting in an average revenue estimate of $59k. In the same quarter a year ago, actual revenue was $17.07kBased on 1 analysts’ estimates, the company’s revenue will be $525k in the next fiscal year. The high estimate is $525k and the low estimate is $525k.
